Article Details
Retrieved on: 2024-05-10 16:04:08
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the growing Diabetic Retinopathy market, projected to rise due to increased disease prevalence and awareness. Emerging treatments like angiogenesis inhibitors (e.g., Ranibizumab, Aflibercept) administered intravitreally are highlighted alongside companies like Unity Biotechnology and Alimera Sciences involved in this therapeutic area, potentially reducing complications like blindness.
Article found on: www.theglobeandmail.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here